BioTuesdays

Category - Markets

CareDx Logo
Markets

HCW cuts CareDx to neutral but ups PT to $15

H.C. Wainwright downgraded CareDx (NASDAQ:CDNA) to “neutral” from “buy” but raised its price target to $15 from $14, citing the company’s valuation. The stock closed at $15.78 on June 18. Earlier this month, CareDx held...

June 19, 2018
Iterum Therapeutics Logo
Markets

Leerink starts Iterum Therapeutics at OP; PT $18

Leerink launched coverage of Iterum Therapeutics (NASDAQ:ITRM) with an “outperform” rating and price target of $18. The stock closed at $12 on June 18. Iterum is developing an IV and oral formulation of sulopenem for...

June 19, 2018
Flex Pharma
Markets

Ladenburg cuts Flex Pharma to neutral, drops PT

Ladenburg Thalmann downgraded Flex Pharm (NASDAQ:FLKS) to “neutral” from “buy” without a price target after the company halted two Phase 2 trials. In afternoon trading on June 13, shares of Flex were quoted at $1.36...

June 13, 2018
Aleafia Health Logo
Markets

Mackie starts Aleafia Health at buy; PT $1.75

Mackie Research initiated coverage of Aleafia Health (TSXV:ALEF) with a “buy” rating and price target of $1.75. The stock closed at 51 cents on June 12. Aleafia runs the largest network of referral-only medical cannabis...

June 13, 2018
Stemline Logo
Markets

Roth starts Stemline Therapeutics at buy; PT $30

Roth Capital Partners initiated coverage of Stemline Therapeutics (NASDAQ:STML) with a “buy” rating and $30 price target. The stock closed at $17.90 on June 11. “We expect Stemline to sail smoothly through a biologics...

June 12, 2018
Tactile Systems Technology
Markets

Canaccord ups Tactile Systems PT to $56

Canaccord Genuity raised its price target for Tactile Systems Technology (NASDAQ:TCMD) to $56 from $46 on the heels of a recent acquisition of IP. The stock closed at $51.37 on June 11. Tactile is a medical device...

June 12, 2018
Tocagen Logo
Markets

HCW starts Tocagen at buy; PT $14.50

H.C. Wainwright initiated coverage of Tocagen (NASDAQ:TOCA) with a “buy” rating and price target of $14.50. The stock closed at $9.64 on June 8. Analyst Swayampakula Ramakanth writes that the company’s lead product...

June 11, 2018
Axsome Therapeutics
Markets

HCW starts Axsome Therapeutics at buy; PT $10

H.C. Wainwright initiated coverage of Axsome Therapeutics (NASDAQ:AXSM) with a “buy” rating and price target of $10. The stock closed at $3.60 on June 6. Axsome, which is focused on central nervous system (CNS)...

June 7, 2018